PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
20-Jul-2023 Agenus Expands Executive Leadership Team Businesswire
20-Jul-2023 Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc. Businesswire
20-Jul-2023 Qualitest Wins Globee Awards for Health & Medical Information Solution and Health & Pharmaceuticals Service Businesswire
20-Jul-2023 Johnson & Johnson Reports Q2 2023 Results Businesswire
20-Jul-2023 LabWare Selected as Honoree of 2023 Drexel LeBow Analytics 50 Award Newswire
20-Jul-2023 LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth Businesswire
20-Jul-2023 GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine Businesswire
20-Jul-2023 Sapreme Appoints Experienced Industry Executives, Dr. Jeanne Bolger and Dr. Andre Hoekema, to its Board of Directors Businesswire
20-Jul-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
20-Jul-2023 Chiesi recognised as one of UK’s Best Workplaces for Women for four consecutive years Chiesi
20-Jul-2023 AHF Applauds Continued Effort to Combat Malaria in Africa Businesswire
20-Jul-2023 New Clinical and Real-World Data for Genentech’s Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss Businesswire
20-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors Businesswire
20-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Arrival (ARVL) on Behalf of Investors Businesswire
19-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Leslie's, Inc. (LESL) on Behalf of Investors Businesswire
19-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors Businesswire
19-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Proterra Inc. (PTRA) on Behalf of Investors Businesswire
19-Jul-2023 Taro to Release First Quarter Results on July 26, 2023 Businesswire
19-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Baxter International Inc. (BAX) on Behalf of Investors Businesswire
19-Jul-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Viasat, Inc. (VSAT) on Behalf of Investors Businesswire